Company profile for Providence Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Providence Therapeutics is a biotechnology company that develops mRNA vaccines for human use. We manufacture our vaccines in house in Toronto, ON under GMP manufacturing conditions. Our mission is to provide safe and effective medicines for people suffering from diseases with unmet medical needs. At Providence, the patient is always the priority. Our lead program is a personalized mRNA-based vaccine against cancer. Using...
Providence Therapeutics is a biotechnology company that develops mRNA vaccines for human use. We manufacture our vaccines in house in Toronto, ON under GMP manufacturing conditions. Our mission is to provide safe and effective medicines for people suffering from diseases with unmet medical needs. At Providence, the patient is always the priority. Our lead program is a personalized mRNA-based vaccine against cancer. Using advanced technology, we identify a patient's tumor mutations and develop a therapeutic vaccine that will elicit an immune response against the tumor cells.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Canada
Address
Address
Providence Therapeutics Holdings Inc. 661 University Avenue, Suite 1300 Toront...
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.fiercebiotech.com/biotech/everest-continues-mrna-ascent-alone-after-shedding-providence-partnership

FIERCE BIOTECH
20 Feb 2024

https://www.globenewswire.com/news-release/2023/06/02/2681172/0/en/Providence-Therapeutics-Announces-Partnership-with-University-Health-Network-UHN-for-mRNA-Therapeutic-Discovery-and-Development.html

GLOBENEWSWIRE
02 Jun 2023

https://www.globenewswire.com/news-release/2023/02/01/2599422/0/en/Providence-Therapeutics-Appoints-Robert-Georgantas-Ph-D-as-President-and-Chief-Technology-Officer.html

GLOBENEWSWIRE
01 Feb 2023

https://www.globenewswire.com/news-release/2022/12/15/2574539/0/en/Providence-Therapeutics-Announces-New-mRNA-Rabies-Vaccine-Program-and-Achievement-of-Preclinical-Proof-of-Concept-Milestone.html

GLOBENEWSWIRE
15 Dec 2022

https://www.globenewswire.com//news-release/2022/11/28/2563090/0/en/Providence-Therapeutics-Presents-Phase-2-Data-on-its-mRNA-COVID-19-Vaccine-Candidate-PTX-COVID19-B-at-the-2022-World-Vaccine-Immunotherapy-Congress.html

GLOBENEWSWIRE
28 Nov 2022

https://providencetherapeutics.com/press-details/providence-therapeutics-appoints-judyanna-yu-as-chief-financial-officer.html

PRESS RELEASE
02 Nov 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty